A CASE OF ALLERGIC CONTACT DERMATITIS CAUSED BY DETERGENTS CONTAINING COCAMIDOPROPYL BETAINE IN WHICH AN IMPURITY WAS THE POSSIBLE CAUSATIVE AGENT

  • Iijima Shigeruko
    Hanamizuki Clinic
  • Murayama Kayo
    Hanamizuki Clinic
  • Takayama Noriko
    Hanamizuki Clinic
  • Akiyama Takumi
    Division of Environmental Chemistry, National Institute of Health Sciences
  • Sugiyama Mariko
    Skin Safety Case Information Network Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine
  • Matsunaga Kayoko
    Skin Safety Case Information Network Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine

Bibliographic Information

Other Title
  • コカミドプロピルベタイン含有洗浄剤によるアレルギー性接触皮膚炎の1例
  • ―洗浄剤に含まれる不純物が原因抗原と考えられた例―

Description

<p>Cocamidopropyl betaine (CAPB) is an amphoteric surfactant. It has several functions, including producing effervescence and washing effects, and thus, it is used in many cleansing products, such as shampoo and liquid body cleansers. Recently, it has become clear that some impurities that arise during the manufacturing process can have sensitizing effects. Herein, we report a case of allergic contact dermatitis caused by detergents containing CAPB, in which an impurity was determined to be the possible causative agent by patch testing and chemical analysis.</p><p>A 64-year-old Japanese female developed a skin rash on the hairlines of her forehead and nuchal region one month before her first visit to our clinic. Later, the rashes, which were composed of desquamative erythema, expanded to her face, neck, upper back, and chest. Patch tests produced positive results for a shampoo and liquid body cleanser (1% aq.) that she had used as well as for CAPB (1% aq.); lauramidopropyl betaine (LAPB) (1% aq.); and lauramidopropyl dimethylamine (LAPDMA) (0.05% aq.), which is an impurity of CAPB. The rashes resolved completely after we instructed her to use products without CAPB and LAPB. When issuing such instructions, clinicians should have correct knowledge about surfactants, such as the differences between cosmetic ingredient names and quasi-drug ingredient names.</p>

Journal

Details 詳細情報について

  • CRID
    1390012638715489152
  • DOI
    10.15036/arerugi.71.1136
  • ISSN
    13477935
    00214884
  • PubMed
    36372425
  • Text Lang
    ja
  • Article Type
    journal article
  • Data Source
    • JaLC
    • PubMed
  • Abstract License Flag
    Disallowed

Report a problem

Back to top